Shares Outstanding for Labcorp Holdings (LH)
According to Labcorp Holdings's latest reported financial statements, the company's latest reported diluted shares outstanding is 83.20M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingShares OutstandingSwitch metric
Latest period
83.20M
YoY change
-0.7%
5Y CAGR
-3.1%
Peak year (2003)
152.13M
Latest annual
83.80M
Shares Outstanding history chart for Labcorp Holdings (LH) from 1988 to 2025
Shares Outstanding history table for Labcorp Holdings (LH) from 1988 to 2025
| Fiscal year | Period ended | Reported | Shares Outstanding | YoY |
|---|---|---|---|---|
| 2025 | 83.80M | -0.7% | ||
| 2024 | 84.40M | -3.7% | ||
| 2023 | 87.60M | -4.4% | ||
| 2022 | 91.60M | -6.1% | ||
| 2021 | 97.50M | -0.5% | ||
| 2020 | 98.00M | -0.6% | ||
| 2019 | 98.60M | -3.9% | ||
| 2018 | 102.60M | -1.3% | ||
| 2017 | 103.90M | -0.4% | ||
| 2016 | 104.30M | +3.7% | ||
| 2015 | 100.60M | +16.4% | ||
| 2014 | 86.40M | -5.9% | ||
| 2013 | 91.80M | -5.7% | ||
| 2012 | 97.40M | -4.3% | ||
| 2011 | 101.80M | -3.4% | ||
| 2010 | 105.40M | -3.4% | ||
| 2009 | 109.10M | -3.6% | ||
| 2008 | 113.20M | -6.7% | ||
| 2007 | 121.32M | -8.9% | ||
| 2006 | 133.21M | -6.5% | ||
| 2005 | 142.51M | -3.8% | ||
| 2004 | 148.16M | -2.6% | ||
| 2003 | 152.13M | +5.8% | ||
| 2002 | 143.84M | +1.8% | ||
| 2001 | 141.34M | +151.8% | ||
| 2000 | 56.14M | +3.0% | ||
| 1999 | 54.48M | +8.1% | ||
| 1998 | 50.40M | +2.5% | ||
| 1997 | 49.17M | +0.1% | ||
| 1996 | 49.12M | +9.8% | ||
| 1995 | 44.73M | +29.8% | ||
| 1994 | 34.46M | -3.7% | ||
| 1993 | 35.78M | -5.3% | ||
| 1992 | 37.77M | -4.6% | ||
| 1991 | 39.58M | -0.6% | ||
| 1990 | 39.81M | -0.0% | ||
| 1989 | 39.82M | +0.5% | ||
| 1988 | 39.60M | — |
Shares Outstanding values are taken from Labcorp Holdings's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual diluted shares outstanding for Labcorp Holdings (LH) came in at 83.80M – edged down 0.7% year-over-year.
Labcorp Holdings diluted shares outstanding compound annual growth for the 2020–2025 (5 years) window is -3.1%, with a net decline across the window.
Labcorp Holdings diluted shares outstanding peaked at 152.13M in 2003; the latest annual figure is 83.80M in 2025 (44.9% below peak).
Across the available history, diluted shares outstanding reached its high of 152.13M in 2003 and its low of 34.46M in 1994.
Labcorp Holdings (LH) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of 1.34B.
Labcorp Holdings Shares Outstanding by Year
Labcorp Holdings Shares Outstanding 2025: 83.80M
Labcorp Holdings diluted shares outstanding in 2025 was 83.80M, edged down 0.7% below 2024.
Labcorp Holdings Shares Outstanding 2024: 84.40M
Labcorp Holdings diluted shares outstanding in 2024 was 84.40M, edged down 3.7% below 2023.
Labcorp Holdings Shares Outstanding 2023: 87.60M
Labcorp Holdings diluted shares outstanding in 2023 was 87.60M, edged down 4.4% below 2022.
Labcorp Holdings Shares Outstanding 2022: 91.60M
Labcorp Holdings diluted shares outstanding in 2022 was 91.60M, declined 6.1% below 2021.
Labcorp Holdings Shares Outstanding 2021: 97.50M
Labcorp Holdings diluted shares outstanding in 2021 was 97.50M.
See more financial history for Labcorp Holdings (LH).
Sector peers — Shares Outstanding
Companies in the same sector as Labcorp Holdings, ranked by their latest diluted shares outstanding.
| Company | Shares Outstanding | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | 4.45B | Healthcare |
| Merck & Co., Inc. (MRK) | 2.51B | Healthcare |
| Johnson & Johnson (JNJ) | 2.43B | Healthcare |
| AbbVie Inc. (ABBV) | 1.77B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | 910.00M | Healthcare |
| Eli Lilly and Company (LLY) | 898.00M | Healthcare |
| AstraZeneca PLC (AZN) | 781.00M | Healthcare |
| Amgen Inc. (AMGN) | 542.00M | Healthcare |
Frequently asked questions
What is Labcorp Holdings's diluted shares outstanding?
- Latest reported diluted shares outstanding for Labcorp Holdings (LH) is 83.20M (period ending December 31, 2025).
How has Labcorp Holdings diluted shares outstanding changed year-over-year?
- Labcorp Holdings (LH) diluted shares outstanding changed -0.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Labcorp Holdings diluted shares outstanding?
- Labcorp Holdings (LH) diluted shares outstanding compound annual growth rate is -3.1% over the most recent 5 years available.
When did Labcorp Holdings diluted shares outstanding hit its highest annual value?
- Labcorp Holdings diluted shares outstanding reached its highest annual value of 152.13M in 2003.
What was Labcorp Holdings diluted shares outstanding in 2024?
- Labcorp Holdings (LH) diluted shares outstanding in 2024 was 84.40M.
What was Labcorp Holdings diluted shares outstanding in 2025?
- Labcorp Holdings (LH) diluted shares outstanding in 2025 was 83.80M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
LH Overview
Company profile, financial tools, and key metrics
LH Revenue Counter
Earns $442.41 every second. See per minute, hour, and day.
LH Earnings Counter
Earns $27.79 per second net profit. See per minute, hour, and day.
LH Economic Scale
Exceeds West Bank and Gaza's GDP. Compare with world economies.
LH What If Invested
What if you had invested $1,000? See historical returns from any date.
LH How It Makes Money
Discover visual breakdown of $13.95B in revenue — where it comes from and where it goes.
LH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LH Daily Price Character
Balanced · 47.4% historical win rate (green days). Streaks & record days.
LH Buybacks
2.17% TTM buyback yield. Shareholder yield & SBC comparison.
LH Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LH Dividend Profile
Yield: 1.12%. Safety: 4/6. See full history.
LH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.